Masimo Corporation MASI and Cleveland Clinic, a nonprofit academic medical center, recently announced their strategic collaboration to improve the standard of patient care while utilizing hospital-based remote patient monitoring (RPM), including TeleCritical Care. The partnership is intended to integrate Cleveland Clinic’s critical care and non-critical care central patient monitoring platforms with Masimo’s Hospital Automation platform. The partnership is likely to provide tools for clinicians that offer enhanced situational awareness and clinical decision-support for hospitalized patients, including the critically ill. More on the Collaboration Masimo’s Hospital Automation platform provides tools to assist physicians in delivering better patient care at the bedside. Monitoring and wearable technology, high-fidelity medical device integration, system-wide surveillance and data visualization applications, and cutting-edge AI capabilities that enable intelligent patient prioritization and make it easier for clinicians to spot changes in patients' conditions are all included in Masimo’s Hospital Automation platform. These decision-support tools are integrated into Masimo’s Hospital Automation platform and utilize the Halo engine technology that identifies deterioration patterns in multiple physiological parameters simultaneously in real time. The Halo tools include Halo ION, a comprehensive, scalable, and customizable continuous early warning score to help streamline patient assessment and clinical workflows. Masimo and Cleveland Clinic are set to work together to develop a new Halo-based decision-support tool as part of their collaboration. This tool will help clinicians identify adverse events earlier and ultimately manage and improve patient outcomes for patients with low, mid, and high acuity. Cleveland Clinic’s existing critical care and non-critical care central monitoring platform provides continuous monitoring of a range of vital signs, including electrocardiogram, for both ICU and non-ICU patients at more than a 2,000-bed capacity. Its hospital-based RPM programs serve 11 hospitals, providing intensivist monitoring, 24/7 critical care nursing, and patient management. Using Masimo's AI-driven decision support tools, automation solutions, and monitoring devices in association with Cleveland Clinic's extensive clinical knowledge and commitment to delivering the best possible care, the collaboration has the potential to greatly reduce staffing shortages, improve care standardization, and advance intensivist and specialist-led care. Masimo’s Past Collaboration In February 2024, Masimo and UCHealth announced their strategic partnership to improve the standard of patient care while utilizing the newest telehealth and virtual care technologies. The partnership intended to take advantage of the unique expertise of both companies and work toward their shared objectives of enhancing patient outcomes, cutting healthcare costs, and changing the way that care is delivered both inside and outside of hospitals. It places a special emphasis on developing technology-enabled care, including virtual and remote care. Industry Prospects Per a report by Grand View Research, the global telehealth market size was valued at $101.2 billion in 2023 and is expected to witness a growth rate of 24.3% from 2024 to 2030. The market growth is driven by advancements in technology, including improved Internet connectivity and the adoption of smartphones, which contribute to the expansion of telehealth by making healthcare services more accessible and convenient for patients. Another growth factor includes the growing demand for remote healthcare services, mainly due to the COVID-19 pandemic, where the need for virtual consultations and remote monitoring has increased. With the given market potential for telehealth services, Masimo’s collaboration with Cleveland Clinic is likely to boost its business and generate additional revenues. Notable Developments Recently, Masimo announced the FDA clearance of its Masimo SET-powered MightySat Medical Pulse Oximeter, available Over-The-Counter to consumers without a prescription, which becomes the first FDA-approved medical fingertip pulse oximeter that customers can directly avail without the need for any formal prescription. Price Performance For the past six months, MASI’s shares have gained 11.2% compared with the industry’s rise of 4.9%. The S&P 500 increased 15% in the same time frame. Zacks Investment Research Image Source: Zacks Investment Research Zacks Rank & Other Stocks to Consider MASI carries a Zacks Rank #2 (Buy) at present. Some other top-ranked stocks in the broader medical space that have announced quarterly results are DaVita DVA, Ecolab ECL and Universal Health Services UHS. DaVita, carrying a Zacks Rank #2 at present, has an estimated long-term growth rate of 13.6%. DVA’s earnings surpassed estimates in each of the trailing four quarters, with the average surprise being 29.4%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. DaVita’s shares have gained 44% compared with the industry’s 20.4% rise in the past year. Ecolab, carrying a Zacks Rank of 2 at present, has an estimated long-term growth rate of 13.3%. ECL’s earnings surpassed estimates in each of the trailing four quarters, the average surprise being 1.7%. Ecolab’s shares have rallied 33.8% against the industry’s 9.3% decline in the past year. Universal Health Services has an Earnings ESP of +2.91% and a Zacks Rank #2 at present. UHS has an estimated earnings growth rate of 30.5% for 2024. UHS’ earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 8.12%. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Ecolab Inc. (ECL):Free Stock Analysis Report Universal Health Services, Inc. (UHS):Free Stock Analysis Report DaVita Inc. (DVA):Free Stock Analysis Report Masimo Corporation (MASI):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Masimo (MASI), Cleveland Clinic Unite to Enhance Patient Care
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...